nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0281	0.241	CbGpPWpGaD
Gabapentin—ADORA1—nerve—amyotrophic lateral sclerosis	0.0143	0.0908	CbGeAlD
Gabapentin—CACNA2D1—hindbrain—amyotrophic lateral sclerosis	0.0111	0.0705	CbGeAlD
Gabapentin—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00933	0.0128	CcSEcCtD
Gabapentin—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00909	0.0125	CcSEcCtD
Gabapentin—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00887	0.0122	CcSEcCtD
Gabapentin—CACNA1B—medulla oblongata—amyotrophic lateral sclerosis	0.00856	0.0543	CbGeAlD
Gabapentin—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.0081	0.0112	CcSEcCtD
Gabapentin—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00776	0.0107	CcSEcCtD
Gabapentin—CACNA1B—spinal cord—amyotrophic lateral sclerosis	0.00764	0.0485	CbGeAlD
Gabapentin—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00761	0.0105	CcSEcCtD
Gabapentin—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00705	0.00971	CcSEcCtD
Gabapentin—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00692	0.00954	CcSEcCtD
Gabapentin—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.0068	0.00937	CcSEcCtD
Gabapentin—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.0068	0.00937	CcSEcCtD
Gabapentin—BCAT1—medulla oblongata—amyotrophic lateral sclerosis	0.00673	0.0427	CbGeAlD
Gabapentin—CACNA1B—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.00671	0.0576	CbGpPWpGaD
Gabapentin—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00669	0.00921	CcSEcCtD
Gabapentin—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00669	0.00921	CcSEcCtD
Gabapentin—CACNA1B—nervous system—amyotrophic lateral sclerosis	0.00643	0.0408	CbGeAlD
Gabapentin—CACNA2D1—brainstem—amyotrophic lateral sclerosis	0.00637	0.0404	CbGeAlD
Gabapentin—CACNA1B—central nervous system—amyotrophic lateral sclerosis	0.00619	0.0393	CbGeAlD
Gabapentin—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00617	0.0085	CcSEcCtD
Gabapentin—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00617	0.0085	CcSEcCtD
Gabapentin—CACNA1B—cerebellum—amyotrophic lateral sclerosis	0.00605	0.0384	CbGeAlD
Gabapentin—BCAT1—spinal cord—amyotrophic lateral sclerosis	0.006	0.0381	CbGeAlD
Gabapentin—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0059	0.00812	CcSEcCtD
Gabapentin—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.0059	0.00812	CcSEcCtD
Gabapentin—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00581	0.00801	CcSEcCtD
Gabapentin—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00581	0.00801	CcSEcCtD
Gabapentin—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00573	0.00789	CcSEcCtD
Gabapentin—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00573	0.00789	CcSEcCtD
Gabapentin—CACNA2D2—spinal cord—amyotrophic lateral sclerosis	0.00551	0.0349	CbGeAlD
Gabapentin—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00758	CcSEcCtD
Gabapentin—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00758	CcSEcCtD
Gabapentin—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0055	0.00758	CcSEcCtD
Gabapentin—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00529	0.00729	CcSEcCtD
Gabapentin—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00719	CcSEcCtD
Gabapentin—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00522	0.00719	CcSEcCtD
Gabapentin—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00516	0.00711	CcSEcCtD
Gabapentin—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00702	CcSEcCtD
Gabapentin—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00702	CcSEcCtD
Gabapentin—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00702	CcSEcCtD
Gabapentin—BCAT1—nervous system—amyotrophic lateral sclerosis	0.00506	0.0321	CbGeAlD
Gabapentin—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00694	CcSEcCtD
Gabapentin—CACNA1B—brain—amyotrophic lateral sclerosis	0.00492	0.0312	CbGeAlD
Gabapentin—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00677	CcSEcCtD
Gabapentin—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00677	CcSEcCtD
Gabapentin—BCAT1—central nervous system—amyotrophic lateral sclerosis	0.00487	0.0309	CbGeAlD
Gabapentin—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00486	0.0067	CcSEcCtD
Gabapentin—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00662	CcSEcCtD
Gabapentin—BCAT1—cerebellum—amyotrophic lateral sclerosis	0.00476	0.0302	CbGeAlD
Gabapentin—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00655	CcSEcCtD
Gabapentin—CACNA2D2—nervous system—amyotrophic lateral sclerosis	0.00464	0.0294	CbGeAlD
Gabapentin—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00634	CcSEcCtD
Gabapentin—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.0046	0.00634	CcSEcCtD
Gabapentin—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00627	CcSEcCtD
Gabapentin—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00455	0.00627	CcSEcCtD
Gabapentin—BCAT1—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.0045	0.0386	CbGpPWpGaD
Gabapentin—CACNA2D2—central nervous system—amyotrophic lateral sclerosis	0.00447	0.0283	CbGeAlD
Gabapentin—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00446	0.00614	CcSEcCtD
Gabapentin—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00608	CcSEcCtD
Gabapentin—CACNA2D2—cerebellum—amyotrophic lateral sclerosis	0.00437	0.0277	CbGeAlD
Gabapentin—ADORA1—medulla oblongata—amyotrophic lateral sclerosis	0.00428	0.0272	CbGeAlD
Gabapentin—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00428	0.0059	CcSEcCtD
Gabapentin—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00584	CcSEcCtD
Gabapentin—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00584	CcSEcCtD
Gabapentin—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00424	0.00584	CcSEcCtD
Gabapentin—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00579	CcSEcCtD
Gabapentin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0042	0.00579	CcSEcCtD
Gabapentin—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00416	0.00573	CcSEcCtD
Gabapentin—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00568	CcSEcCtD
Gabapentin—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00563	CcSEcCtD
Gabapentin—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00563	CcSEcCtD
Gabapentin—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00405	0.00558	CcSEcCtD
Gabapentin—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00553	CcSEcCtD
Gabapentin—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00401	0.00553	CcSEcCtD
Gabapentin—Mania—Riluzole—amyotrophic lateral sclerosis	0.00398	0.00548	CcSEcCtD
Gabapentin—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00538	CcSEcCtD
Gabapentin—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00534	CcSEcCtD
Gabapentin—BCAT1—brain—amyotrophic lateral sclerosis	0.00387	0.0245	CbGeAlD
Gabapentin—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00384	0.00529	CcSEcCtD
Gabapentin—ADORA1—spinal cord—amyotrophic lateral sclerosis	0.00382	0.0242	CbGeAlD
Gabapentin—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00516	CcSEcCtD
Gabapentin—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00371	0.00512	CcSEcCtD
Gabapentin—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00503	CcSEcCtD
Gabapentin—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.0036	0.00496	CcSEcCtD
Gabapentin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00492	CcSEcCtD
Gabapentin—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00492	CcSEcCtD
Gabapentin—CACNA2D2—brain—amyotrophic lateral sclerosis	0.00355	0.0225	CbGeAlD
Gabapentin—Gamma-glutamyltransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00484	CcSEcCtD
Gabapentin—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00341	0.0047	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00335	0.0287	CbGpPWpGaD
Gabapentin—CACNA2D1—nervous system—amyotrophic lateral sclerosis	0.00334	0.0212	CbGeAlD
Gabapentin—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00457	CcSEcCtD
Gabapentin—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00329	0.00453	CcSEcCtD
Gabapentin—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00327	0.0045	CcSEcCtD
Gabapentin—ADORA1—nervous system—amyotrophic lateral sclerosis	0.00322	0.0204	CbGeAlD
Gabapentin—CACNA2D1—central nervous system—amyotrophic lateral sclerosis	0.00321	0.0204	CbGeAlD
Gabapentin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00441	CcSEcCtD
Gabapentin—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00438	CcSEcCtD
Gabapentin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00438	CcSEcCtD
Gabapentin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00435	CcSEcCtD
Gabapentin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00435	CcSEcCtD
Gabapentin—CACNA2D1—cerebellum—amyotrophic lateral sclerosis	0.00314	0.0199	CbGeAlD
Gabapentin—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00432	CcSEcCtD
Gabapentin—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00312	0.00429	CcSEcCtD
Gabapentin—ADORA1—central nervous system—amyotrophic lateral sclerosis	0.0031	0.0197	CbGeAlD
Gabapentin—Gout—Riluzole—amyotrophic lateral sclerosis	0.0031	0.00427	CcSEcCtD
Gabapentin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00421	CcSEcCtD
Gabapentin—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00421	CcSEcCtD
Gabapentin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00418	CcSEcCtD
Gabapentin—ADORA1—cerebellum—amyotrophic lateral sclerosis	0.00303	0.0192	CbGeAlD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00297	0.0255	CbGpPWpGaD
Gabapentin—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00408	CcSEcCtD
Gabapentin—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00406	CcSEcCtD
Gabapentin—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00406	CcSEcCtD
Gabapentin—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00403	CcSEcCtD
Gabapentin—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00398	CcSEcCtD
Gabapentin—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00398	CcSEcCtD
Gabapentin—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00398	CcSEcCtD
Gabapentin—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00394	CcSEcCtD
Gabapentin—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00282	0.00389	CcSEcCtD
Gabapentin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00385	CcSEcCtD
Gabapentin—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00385	CcSEcCtD
Gabapentin—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0038	CcSEcCtD
Gabapentin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00378	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00274	0.0235	CbGpPWpGaD
Gabapentin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00374	CcSEcCtD
Gabapentin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00366	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00265	0.0227	CbGpPWpGaD
Gabapentin—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0036	CcSEcCtD
Gabapentin—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00355	CcSEcCtD
Gabapentin—CACNA2D1—brain—amyotrophic lateral sclerosis	0.00255	0.0162	CbGeAlD
Gabapentin—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00349	CcSEcCtD
Gabapentin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00346	CcSEcCtD
Gabapentin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00346	CcSEcCtD
Gabapentin—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00342	CcSEcCtD
Gabapentin—ADORA1—brain—amyotrophic lateral sclerosis	0.00246	0.0156	CbGeAlD
Gabapentin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00339	CcSEcCtD
Gabapentin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00339	CcSEcCtD
Gabapentin—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00336	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00242	0.0208	CbGpPWpGaD
Gabapentin—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00332	CcSEcCtD
Gabapentin—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00241	0.00332	CcSEcCtD
Gabapentin—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00331	CcSEcCtD
Gabapentin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00323	CcSEcCtD
Gabapentin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00323	CcSEcCtD
Gabapentin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00322	CcSEcCtD
Gabapentin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00319	CcSEcCtD
Gabapentin—Injury—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00315	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00227	0.0195	CbGpPWpGaD
Gabapentin—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00226	0.00312	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00225	0.0193	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00225	0.0193	CbGpPWpGaD
Gabapentin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00308	CcSEcCtD
Gabapentin—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00308	CcSEcCtD
Gabapentin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00305	CcSEcCtD
Gabapentin—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00304	CcSEcCtD
Gabapentin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00218	0.003	CcSEcCtD
Gabapentin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00298	CcSEcCtD
Gabapentin—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00296	CcSEcCtD
Gabapentin—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00211	0.0029	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0021	0.018	CbGpPWpGaD
Gabapentin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00289	CcSEcCtD
Gabapentin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00289	CcSEcCtD
Gabapentin—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00287	CcSEcCtD
Gabapentin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00285	CcSEcCtD
Gabapentin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00285	CcSEcCtD
Gabapentin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00282	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00203	0.0174	CbGpPWpGaD
Gabapentin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00203	0.00279	CcSEcCtD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00201	0.0172	CbGpPWpGaD
Gabapentin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.002	0.00275	CcSEcCtD
Gabapentin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.002	0.00275	CcSEcCtD
Gabapentin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00274	CcSEcCtD
Gabapentin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00272	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00197	0.0169	CbGpPWpGaD
Gabapentin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00269	CcSEcCtD
Gabapentin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00267	CcSEcCtD
Gabapentin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00261	CcSEcCtD
Gabapentin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00256	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00185	0.0159	CbGpPWpGaD
Gabapentin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00255	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00181	0.0156	CbGpPWpGaD
Gabapentin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0025	CcSEcCtD
Gabapentin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0025	CcSEcCtD
Gabapentin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00181	0.0025	CcSEcCtD
Gabapentin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00245	CcSEcCtD
Gabapentin—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00243	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00175	0.015	CbGpPWpGaD
Gabapentin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00174	0.0024	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00172	0.0148	CbGpPWpGaD
Gabapentin—CACNA1B—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00172	0.0148	CbGpPWpGaD
Gabapentin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00234	CcSEcCtD
Gabapentin—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00231	CcSEcCtD
Gabapentin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0023	CcSEcCtD
Gabapentin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00228	CcSEcCtD
Gabapentin—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00227	CcSEcCtD
Gabapentin—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00226	CcSEcCtD
Gabapentin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00224	CcSEcCtD
Gabapentin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00223	CcSEcCtD
Gabapentin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00223	CcSEcCtD
Gabapentin—Depression—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00222	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0016	0.0138	CbGpPWpGaD
Gabapentin—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00159	0.0022	CcSEcCtD
Gabapentin—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00218	CcSEcCtD
Gabapentin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00218	CcSEcCtD
Gabapentin—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00217	CcSEcCtD
Gabapentin—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00217	CcSEcCtD
Gabapentin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00217	CcSEcCtD
Gabapentin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00214	CcSEcCtD
Gabapentin—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00212	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00154	0.0132	CbGpPWpGaD
Gabapentin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00211	CcSEcCtD
Gabapentin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0021	CcSEcCtD
Gabapentin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00209	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00151	0.0129	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00149	0.0128	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00149	0.0128	CbGpPWpGaD
Gabapentin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00204	CcSEcCtD
Gabapentin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00201	CcSEcCtD
Gabapentin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.002	CcSEcCtD
Gabapentin—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00145	0.002	CcSEcCtD
Gabapentin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00199	CcSEcCtD
Gabapentin—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00199	CcSEcCtD
Gabapentin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00199	CcSEcCtD
Gabapentin—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00198	CcSEcCtD
Gabapentin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00197	CcSEcCtD
Gabapentin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00197	CcSEcCtD
Gabapentin—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00196	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00139	0.0119	CbGpPWpGaD
Gabapentin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00189	CcSEcCtD
Gabapentin—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00187	CcSEcCtD
Gabapentin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00186	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00134	0.0115	CbGpPWpGaD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00133	0.0114	CbGpPWpGaD
Gabapentin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00181	CcSEcCtD
Gabapentin—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0018	CcSEcCtD
Gabapentin—Chills—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00179	CcSEcCtD
Gabapentin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00177	CcSEcCtD
Gabapentin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00175	CcSEcCtD
Gabapentin—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00174	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—amyotrophic lateral sclerosis	0.00126	0.0108	CbGpPWpGaD
Gabapentin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00172	CcSEcCtD
Gabapentin—Tension—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00171	CcSEcCtD
Gabapentin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00171	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00123	0.0105	CbGpPWpGaD
Gabapentin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00169	CcSEcCtD
Gabapentin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00168	CcSEcCtD
Gabapentin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00167	CcSEcCtD
Gabapentin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00163	CcSEcCtD
Gabapentin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00162	CcSEcCtD
Gabapentin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00161	CcSEcCtD
Gabapentin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00116	0.0016	CcSEcCtD
Gabapentin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00159	CcSEcCtD
Gabapentin—BCAT1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00114	0.0098	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00114	0.0098	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00114	0.00979	CbGpPWpGaD
Gabapentin—CACNA2D2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00114	0.00979	CbGpPWpGaD
Gabapentin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00157	CcSEcCtD
Gabapentin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00156	CcSEcCtD
Gabapentin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00156	CcSEcCtD
Gabapentin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00156	CcSEcCtD
Gabapentin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00154	CcSEcCtD
Gabapentin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00153	CcSEcCtD
Gabapentin—Cough—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00152	CcSEcCtD
Gabapentin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00151	CcSEcCtD
Gabapentin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0015	CcSEcCtD
Gabapentin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00148	CcSEcCtD
Gabapentin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00148	CcSEcCtD
Gabapentin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00148	CcSEcCtD
Gabapentin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00148	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00147	CcSEcCtD
Gabapentin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00146	CcSEcCtD
Gabapentin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00145	CcSEcCtD
Gabapentin—BCAT1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00105	0.00897	CbGpPWpGaD
Gabapentin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00143	CcSEcCtD
Gabapentin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00142	CcSEcCtD
Gabapentin—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00142	CcSEcCtD
Gabapentin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00141	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00102	0.00873	CbGpPWpGaD
Gabapentin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00101	0.0014	CcSEcCtD
Gabapentin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00139	CcSEcCtD
Gabapentin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00139	CcSEcCtD
Gabapentin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00139	CcSEcCtD
Gabapentin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.001	0.00138	CcSEcCtD
Gabapentin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000997	0.00137	CcSEcCtD
Gabapentin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000983	0.00135	CcSEcCtD
Gabapentin—BCAT1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000972	0.00834	CbGpPWpGaD
Gabapentin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00133	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00094	0.00129	CcSEcCtD
Gabapentin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000933	0.00129	CcSEcCtD
Gabapentin—ADORA1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00093	0.00797	CbGpPWpGaD
Gabapentin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000926	0.00128	CcSEcCtD
Gabapentin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00127	CcSEcCtD
Gabapentin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00126	CcSEcCtD
Gabapentin—BCAT1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000914	0.00784	CbGpPWpGaD
Gabapentin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000908	0.00125	CcSEcCtD
Gabapentin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00124	CcSEcCtD
Gabapentin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000891	0.00123	CcSEcCtD
Gabapentin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000889	0.00123	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000889	0.00763	CbGpPWpGaD
Gabapentin—Pain—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00122	CcSEcCtD
Gabapentin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000882	0.00122	CcSEcCtD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.000857	0.00735	CbGpPWpGaD
Gabapentin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00117	CcSEcCtD
Gabapentin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000844	0.00116	CcSEcCtD
Gabapentin—BCAT1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000826	0.00709	CbGpPWpGaD
Gabapentin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00113	CcSEcCtD
Gabapentin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000815	0.00112	CcSEcCtD
Gabapentin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000815	0.00112	CcSEcCtD
Gabapentin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00076	0.00105	CcSEcCtD
Gabapentin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00074	0.00102	CcSEcCtD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000739	0.00634	CbGpPWpGaD
Gabapentin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00101	CcSEcCtD
Gabapentin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000706	0.000972	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000692	0.00594	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000692	0.00594	CbGpPWpGaD
Gabapentin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000682	0.00094	CcSEcCtD
Gabapentin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000656	0.000904	CcSEcCtD
Gabapentin—Rash—Riluzole—amyotrophic lateral sclerosis	0.00065	0.000896	CcSEcCtD
Gabapentin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00065	0.000895	CcSEcCtD
Gabapentin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00089	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000633	0.00543	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000626	0.00537	CbGpPWpGaD
Gabapentin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000613	0.000844	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000589	0.00505	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000578	0.00496	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000563	0.00483	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000554	0.00475	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000501	0.00429	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000475	0.00407	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000406	0.00348	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000379	0.00325	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00035	0.003	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000323	0.00277	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000318	0.00273	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000289	0.00248	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000288	0.00247	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000255	0.00219	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000246	0.00211	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000234	0.00201	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000225	0.00193	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000212	0.00182	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000201	0.00172	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000194	0.00167	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000193	0.00165	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000175	0.0015	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000173	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000171	0.00146	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000155	0.00133	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000143	0.00122	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000142	0.00122	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000139	0.00119	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000132	0.00113	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000126	0.00108	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000117	0.00101	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000117	0.001	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00011	0.000943	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000105	0.000898	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.96e-05	0.000769	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.43e-05	0.000723	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.01e-05	0.000687	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.45e-05	0.000639	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.93e-05	0.000595	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.73e-05	0.000491	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.41e-05	0.000378	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.17e-05	0.000357	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.74e-05	0.000321	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.83e-05	0.000243	CbGpPWpGaD
